At a glance
ClinicalIndex Comparison RecordN/ACompleted· 56 enrolled
Drug / intervention
MRI scanprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems
In Brief
A clinical study evaluating MRI scan for Chronic Pain. Completed, enrolled 56 participants across 10 sites in 7 countries.
Detailed Summary
A post market study evaluating the safety of the Prodigy MRI and Proclaim Elite MR conditional Spinal Cord Stimulator (SCS) systems.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesAustria, Belgium, Germany, Italy, Spain, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartOct 2016
Primary CompletionDec 2020
Study CompletionDec 2020
TodayJul 2026
First PostedApr 14, 2016
Enrollment StartOct 21, 2016
Primary CompletionDec 1, 2020
Study CompletionDec 2, 2020
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 10.2 years ago
Interventions
MRI scanprocedure
MRI scan